•
|
Diluted earnings per common share (“EPS”) of $0.74 versus $1.11.
|
•
|
Consolidated sales decreased 5.9% to $224.8 million. Comparable-store sales decreased 6.7%.
|
•
|
Gross profit margin increased to 59.1% from 59.0%.
|
Results of Operations
|
||||||||
Three Months Ended March 31,
|
||||||||
2023
|
2022
|
|||||||
Sales
|
$
|
224.8
|
$
|
238.9
|
||||
Gross Profit
|
132.8
|
141.0
|
||||||
Gross profit as a % of sales
|
59.1
|
%
|
59.0
|
%
|
||||
SGA
|
||||||||
Variable
|
44.9
|
44.4
|
||||||
Fixed
|
73.5
|
70.8
|
||||||
Total
|
118.4
|
115.2
|
||||||
SGA as a % of sales
|
||||||||
Variable
|
20.0
|
%
|
18.6
|
%
|
||||
Fixed
|
32.7
|
%
|
29.6
|
%
|
||||
Total
|
52.7
|
%
|
48.2
|
%
|
||||
Pre-tax income
|
15.4
|
25.7
|
||||||
Pre-tax income as a % of sales
|
6.9
|
%
|
10.8
|
%
|
||||
Net income
|
12.4
|
19.4
|
||||||
Net income as a % of sales
|
5.5
|
%
|
8.1
|
%
|
||||
Diluted earnings per share (“EPS”)
|
$
|
0.74
|
$
|
1.11
|
Other Financial and Operations Data
|
||||||||
Three Months Ended March 31,
|
||||||||
2023
|
2022
|
|||||||
EBITDA (in millions)(1)
|
$
|
18.8
|
$
|
29.9
|
||||
Sales per square foot
|
$
|
208
|
$
|
222
|
||||
Average ticket
|
$
|
3,192
|
$
|
3,066
|
Liquidity Measures
|
|||||||||||||||||
Three Months Ended March 31,
|
Three Months Ended March 31,
|
||||||||||||||||
Free Cash Flow
|
2023
|
2022
|
Cash Returns to Shareholders
|
2023
|
2022
|
||||||||||||
Operating cash flow
|
$
|
11.1
|
$
|
20.6
|
Share repurchases
|
$
|
—
|
$
|
12.5
|
||||||||
Dividends
|
4.5
|
4.3
|
|||||||||||||||
Capital expenditures
|
(6.7
|
)
|
(7.1
|
)
|
Cash returns to shareholders
|
$
|
4.5
|
$
|
16.8
|
||||||||
Free cash flow
|
$
|
4.4
|
$
|
13.5
|
|||||||||||||
Cash at period end
|
$
|
127.0
|
$
|
169.1
|
(1)
|
See the reconciliation of the non-GAAP metrics at the end of the release.
|
•
|
Total sales down 5.9%, comp-store sales down 6.7% for the quarter. Total written sales were down 11.7% and written comp-store sales declined 12.7% for the quarter.
|
•
|
Gross profit margins increased to 59.1% in 2023 from 59.0% in 2022.
|
•
|
SG&A expenses were 52.7% of sales versus 48.2% and increased $3.2 million. The primary drivers of this change are:
|
◦
|
increase of $1.4 million in selling expenses due to the impact of rising interest rates on third-party credit costs partially offset by lower commissioned-based
compensation expense.
|
◦
|
increase of $2.0 million in occupancy costs driven by higher maintenance and tax costs.
|
◦
|
increase in administrative expense of $1.3 million primarily from higher health insurance costs and professional services.
|
◦
|
decrease in warehouse and delivery costs of $1.4 million primarily from $0.9 million lower demurrage fees and a reduction in usage of temporary labor.
|
•
|
Cash, cash equivalents, and restricted cash equivalents at March 31, 2023 are $127.0 million.
|
•
|
Generated $11.1 million in cash from operating activities primarily from solid earnings
performance and changes in working capital including $15.0 million in vendor repayments and accrued liabilities, a decrease in inventories of $4.1 million, and an increase in other assets and liabilities of $5.7 million.
|
•
|
Paid $4.5 million in quarterly cash dividends during the three months ended March 31, 2023.
|
•
|
No debt outstanding at March 31, 2023 and credit availability of $80.0 million.
|
•
|
We expect gross profit margins for 2023 will be between 58.5% to 59.0%. Gross profit
margins fluctuate quarter to quarter in relation to our promotional cadence. Our estimated gross profit margins are based on anticipated changes in product and freight costs and its impact on our LIFO reserve.
|
•
|
Fixed and discretionary expenses within SG&A for the full year of 2023 are expected to be in the $289.0 to $292.0 million range, a reduction in our previous
guidance related to advertising and warehouse and delivery costs. Variable SG&A expenses for the full year of 2023 are anticipated to be in the 19.5% to 19.7% range.
|
•
|
Our effective tax rate for 2023 is expected to be 25% excluding the impact from the
vesting of stock-based awards, potential tax credits, and any new tax legislation.
|
•
|
Planned capital expenditures for 2023 have changed from our previous guidance and are
approximately $53.1 million in 2023. We expect retail square footage will increase approximately 1.6% as we plan to open four stores and close one. Our capital
expenditures estimate also includes the expected purchase of our Florida distribution center from our landlord in May for approximately $28.2 million.
|
Three Months Ended
March 31, |
||||||||
(In thousands, except per share data)
|
2023
|
2022
|
||||||
Net sales
|
$
|
224,754
|
$
|
238,946
|
||||
Cost of goods sold
|
91,969
|
97,985
|
||||||
Gross profit
|
132,785
|
140,961
|
||||||
Expenses:
|
||||||||
Selling, general and administrative
|
118,361
|
115,154
|
||||||
Other (income) expense, net
|
(4
|
)
|
161
|
|||||
Total expenses
|
118,357
|
115,315
|
||||||
Income before interest and income taxes
|
14,428
|
25,646
|
||||||
Interest income, net
|
1,010
|
74
|
||||||
Income before income taxes
|
15,438
|
25,720
|
||||||
Income tax expense
|
3,066
|
6,359
|
||||||
Net income
|
$
|
12,372
|
$
|
19,361
|
||||
Basic earnings per share:
|
||||||||
Common Stock
|
$
|
0.77
|
$
|
1.14
|
||||
Class A Common Stock
|
$
|
0.72
|
$
|
1.08
|
||||
Diluted earnings per share:
|
||||||||
Common Stock
|
$
|
0.74
|
$
|
1.11
|
||||
Class A Common Stock
|
$
|
0.71
|
$
|
1.05
|
||||
Cash dividends per share:
|
||||||||
Common Stock
|
$
|
0.28
|
$
|
0.25
|
||||
Class A Common Stock
|
$
|
0.26
|
$
|
0.23
|
(In thousands)
|
March 31,
2023 |
December 31,
2022 |
March 31,
2022 |
|||||||||
Assets
|
||||||||||||
Current assets
|
||||||||||||
Cash and cash equivalents
|
$
|
120,170
|
$
|
123,126
|
$
|
162,340
|
||||||
Restricted cash and cash equivalents
|
6,876
|
6,804
|
6,715
|
|||||||||
Inventories
|
114,254
|
118,333
|
119,857
|
|||||||||
Prepaid expenses
|
11,430
|
9,707
|
10,633
|
|||||||||
Other current assets
|
19,590
|
18,283
|
13,585
|
|||||||||
Total current assets
|
272,320
|
276,253
|
313,130
|
|||||||||
Property and equipment, net
|
139,212
|
137,475
|
128,721
|
|||||||||
Right-of-use lease assets
|
207,673
|
207,390
|
221,083
|
|||||||||
Deferred income taxes
|
16,332
|
15,501
|
18,252
|
|||||||||
Other assets
|
12,878
|
12,430
|
12,699
|
|||||||||
Total assets
|
$
|
648,415
|
$
|
649,049
|
$
|
693,885
|
||||||
Liabilities and Stockholders’ Equity
|
||||||||||||
Current liabilities
|
||||||||||||
Accounts payable
|
$
|
15,632
|
$
|
23,345
|
$
|
32,415
|
||||||
Customer deposits
|
46,382
|
47,969
|
98,528
|
|||||||||
Accrued liabilities
|
40,372
|
48,676
|
48,876
|
|||||||||
Current lease liabilities
|
36,180
|
34,442
|
33,923
|
|||||||||
Total current liabilities
|
138,566
|
154,432
|
213,742
|
|||||||||
Noncurrent lease liabilities
|
185,866
|
186,845
|
197,265
|
|||||||||
Other liabilities
|
27,571
|
18,373
|
22,478
|
|||||||||
Total liabilities
|
352,003
|
359,650
|
433,485
|
|||||||||
Stockholders’ equity
|
296,412
|
289,399
|
260,400
|
|||||||||
Total liabilities and stockholders’ equity
|
$
|
648,415
|
$
|
649,049
|
$
|
693,885
|
(In thousands)
|
Three Months Ended
March 31, |
|||||||
2023
|
2022
|
|||||||
Cash Flows from Operating Activities:
|
||||||||
Net income
|
$
|
12,372
|
$
|
19,361
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation and amortization
|
4,362
|
4,272
|
||||||
Share-based compensation expense
|
1,957
|
2,307
|
||||||
Other
|
(840
|
)
|
(1,877
|
)
|
||||
Changes in operating assets and liabilities:
|
||||||||
Inventories
|
4,079
|
(7,826
|
)
|
|||||
Customer deposits
|
(1,587
|
)
|
(369
|
)
|
||||
Other assets and liabilities
|
5,721
|
1,120
|
||||||
Accounts payable and accrued liabilities
|
(14,990
|
)
|
3,590
|
|||||
Net cash provided by operating activities
|
11,074
|
20,578
|
||||||
Cash Flows from Investing Activities:
|
||||||||
Capital expenditures
|
(6,655
|
)
|
(7,107
|
)
|
||||
Proceeds from sale of land, property and equipment
|
13
|
—
|
||||||
Net cash used in investing activities
|
(6,642
|
)
|
(7,107
|
)
|
||||
Cash Flows from Financing Activities:
|
||||||||
Dividends paid
|
(4,528
|
)
|
(4,260
|
)
|
||||
Common stock repurchased
|
—
|
(12,501
|
)
|
|||||
Other
|
(2,788
|
)
|
(517
|
)
|
||||
Net cash used in financing activities
|
(7,316
|
)
|
(17,278
|
)
|
||||
Decrease in cash, cash equivalents and restricted cash equivalents during the period
|
(2,884
|
)
|
(3,807
|
)
|
||||
Cash, cash equivalents and restricted cash equivalents at beginning of period
|
129,930
|
172,862
|
||||||
Cash, cash equivalents and restricted cash equivalents at end of period
|
$
|
127,046
|
$
|
169,055
|
Three Months Ended March 31,
|
||||||||
(in thousands)
|
2023
|
2022
|
||||||
Income before income taxes, as reported
|
$
|
15,438
|
$
|
25,720
|
||||
Interest income, net
|
(1,010
|
)
|
(74
|
)
|
||||
Depreciation
|
4,362
|
4,272
|
||||||
EBITDA
|
$
|
18,790
|
$
|
29,918
|